APA ציטוט

Runnebaum, I. B., Reichert, D., Ringsdorf, U., Kuther, M., Hesse, T., Sehouli, J., & Wimberger, P. (2018). Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: A prospective, observational, multicenter study. J Cancer Res Clin Oncol.

Citação norma Chicago

Runnebaum, Ingo B., Dietmar Reichert, Uta Ringsdorf, Markus Kuther, Tobias Hesse, Jalid Sehouli, and Pauline Wimberger. "Trabectedin Plus Pegylated Liposomal Doxorubicin (PLD) for Patients With Platinum-sensitive Recurrent Ovarian Cancer: A Prospective, Observational, Multicenter Study." J Cancer Res Clin Oncol 2018.

ציטוט MLA

Runnebaum, Ingo B., et al. "Trabectedin Plus Pegylated Liposomal Doxorubicin (PLD) for Patients With Platinum-sensitive Recurrent Ovarian Cancer: A Prospective, Observational, Multicenter Study." J Cancer Res Clin Oncol 2018.